ID: ALA4100414

Max Phase: Preclinical

Molecular Formula: C10H8N4O3

Molecular Weight: 232.20

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(Nc1ncc[nH]1)c1cccc([N+](=O)[O-])c1

Standard InChI:  InChI=1S/C10H8N4O3/c15-9(13-10-11-4-5-12-10)7-2-1-3-8(6-7)14(16)17/h1-6H,(H2,11,12,13,15)

Standard InChI Key:  SXOYSAUXPPSOPO-UHFFFAOYSA-N

Associated Targets(non-human)

MDCK-II 565 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 232.20Molecular Weight (Monoisotopic): 232.0596AlogP: 1.57#Rotatable Bonds: 3
Polar Surface Area: 100.92Molecular Species: NEUTRALHBA: 4HBD: 2
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 11.16CX Basic pKa: 3.67CX LogP: 1.57CX LogD: 1.57
Aromatic Rings: 2Heavy Atoms: 17QED Weighted: 0.62Np Likeness Score: -1.89

References

1. Siddiqui-Jain A, Hoj JP, Hargiss JB, Hoj TH, Payne CJ, Ritchie CA, Herron SR, Quinn C, Schuler JT, Hansen MDH..  (2017)  Pyridine-pyrimidine amides that prevent HGF-induced epithelial scattering by two distinct mechanisms.,  27  (17): [PMID:28780159] [10.1016/j.bmcl.2017.07.063]

Source